Acotec Scientific Holdings Limited announced that, Mr. Silvio Rudolf SCHAFFNER ("Mr. Schaffner") was re-designated from an executive director and the chief operating officer of the Company to a non-executive director of the Company with the effect from June 12, 2024, as he would like to devote more time on his other engagements. Mr. Silvio Rudolf SCHAFFNER, aged 54, was appointed as a director of the Company on December 3, 2020 and re-designated as an executive director on January 29, 2021 and a non- executive Director on June 12, 2024, respectively. He was the chief operating officer of Acotec Scientific Co.

Ltd., an indirect wholly-owned subsidiary of the Company, from March 10, 2017 to June 12, 2024, overseeing the overall strategic planning, business direction and operational management of the Company. Mr. Schaffner has over 30 years of experience in the medical devices industry. He holds various patents in orthopedic implantation and vascular intervention fields.

From December 2004 to June 2010, Mr. Schaffner served as the managing director and the legal representative of Invatec. Before joining Invatec, Mr. Schaffner successively served as the Head of Polymer Research at Sulzer Orthopedics Ltd. and then head of R&D at Jomed NV (acquired by Abbott in 2003) from 1993 to 2003. Mr. Schaffner obtained his diploma in mechanical engineering from University Brugg-Windisch in Switzerland in November 1993 and his master's degree in business administration from University of St.

Gallen in Switzerland in October 1997. During his tenure as an executive director and chief operating officer, Mr. Schaffner faithfully performed his duties and contributed to the Company's development. Mr. Schaffner will continue to support the Company as a non-executive director.

The Board would like to take this opportunity to express its sincere gratitude to Mr. Schaffner for his valuable contributions to the Company.